thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastic agents - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients
eremfat i.v. 600mg powder for solution for infusion
riemser arzneimittel ag - rifampicin 600 mg - powder for solution for infusion
pyrafat 500mg film-coated tablets
riemser arzneimittel ag - pyrazinamide 500 mg - film-coated tablet
isoniazid 100mg tablets
morningside healthcare ltd - isoniazid - oral tablet - 100mg
thiotepa riemser 100 mg
a.l. medi-market ltd. - thiotepa - powder for concentrate for solution for infusion - thiotepa 100 mg/vial - thiotepa - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
thiotepa riemser 15 mg
a.l. medi-market ltd. - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg/vial - thiotepa - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
paclitaxel 6 mg/ml concentrate for solution for infusion
riemser pharma gmbh - paclitaxel - concentrate for solution for infusion - 6 milligram(s)/millilitre - taxanes; paclitaxel
ethambutol 400mg tablets
a a h pharmaceuticals ltd - ethambutol hydrochloride - oral tablet - 400mg
ethambutol 400mg tablets
kent pharma (uk) ltd - ethambutol hydrochloride - oral tablet - 400mg
ethambutol 400mg tablets
alliance healthcare (distribution) ltd - ethambutol hydrochloride - oral tablet - 400mg